x
Ariana Pharma - Logo
[contact-form-7 404 "Not Found"]

  • Paris, FRANCE / Cambridge, MA, USA
  • 666-888-0000
  • info@arianapharma.com
Ariana Pharma - Logo
  • info@arianapharma.com
  • Paris, FRANCE / Cambridge, MA, USA
  • Contact Us
  • Home
  • Our Business
  • Our Technology
  • About Us
  • News
    • In The News
    • Publications
  • Real World Data
  • Careers
Logo

Contact Info

  • 58-60 Avenue de la Grande Armée, 75017, Paris, France
  • +33 1 44 37 17 00
  • info@arianapharma.com

Category: Type A Diabetes

Type A Diabetes
Ariana Pharma - Img

Sep2019

Towards a first precision medicine Immunotherapy for the treatment of Type 1 Diabetes using Ariana’s Artificial Intelligence

Ariana’s KEM® Artificial Intelligence technology identified immunological changes, which are early indicators of clinical effects, for selected groups of patients in a first-in-human Phase 1b study. The potential for a selection biomarker in patients receiving this therapy transforms design options for Imcyse’s future clinical trials in T1D and additional indications. On August 27th 2019, Imcyse, […]

Read More

Categories

  • Alzheimer's
  • Autism
  • Autoimmune disease
  • Cancer
  • Fibromyalgia
  • Kidney Transplant
  • Parkinson’s
  • Precision Medicine
  • Publications
  • Real World Evidence
  • Recent Posts
  • Type A Diabetes
  • Uncategorized

Tags

alzheimer's autism cancer Event Fibromyalgia Graft rejection Influenza Kidney Laboratory lung neurological Parkinson Parkinson’s precisionmedicine precision medicine publication realworldevidence recent post Recent Posts Research Transplant vaccine

Ariana Pharmaceuticals, The AI DRUG Development Company

  • Paris, FRANCE / Cambridge, MA, USA
  • Call Us: +33 144 37 17 00
  • info@arianapharma.com

Menu

  • About Us
  • Our business
  • Technology
  • In The News
  • Contact Us

Subscribe

Keep in touch and subscribe to our latest news

    Ariana Pharma © 2022 All Rights Reserved